|
Name |
(Z)-7-[(2R,3S)-3-[(2Z,5E)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoic acid
|
Molecular Formula | C20H32O3 | |
IUPAC Name* |
(Z)-7-[(2R,3S)-3-[(2Z,5E)-undeca-2,5-dienyl]oxiran-2-yl]hept-5-enoic acid
|
|
SMILES |
CCCCC/C=C/C/C=C\C[C@H]1[C@H](O1)C/C=C\CCCC(=O)O
|
|
InChI |
InChI=1S/C20H32O3/c1-2-3-4-5-6-7-8-9-12-15-18-19(23-18)16-13-10-11-14-17-20(21)22/h6-7,9-10,12-13,18-19H,2-5,8,11,14-17H2,1H3,(H,21,22)/b7-6+,12-9-,13-10-/t18-,19+/m0/s1
|
|
InChIKey |
DBWQSCSXHFNTMO-YCBVFNAUSA-N
|
|
Synonyms |
8(9)-EET; 82864-43-5; 5-Heptenoic acid, 7-(3-(2,5-undecadienyl)oxiranyl)-, (2alpha(Z),3alpha(2Z,5Z))-
|
|
CAS | 82864-43-5 | |
PubChem CID | 6440706 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 320.5 | ALogp: | 5.4 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 49.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 23 | QED Weighted: | 0.256 |
Caco-2 Permeability: | -5.119 | MDCK Permeability: | 0.00003470 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.053 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.004 | Plasma Protein Binding (PPB): | 99.60% |
Volume Distribution (VD): | 0.425 | Fu: | 0.66% |
CYP1A2-inhibitor: | 0.038 | CYP1A2-substrate: | 0.672 |
CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.147 |
CYP2C9-inhibitor: | 0.184 | CYP2C9-substrate: | 0.987 |
CYP2D6-inhibitor: | 0.031 | CYP2D6-substrate: | 0.888 |
CYP3A4-inhibitor: | 0.076 | CYP3A4-substrate: | 0.059 |
Clearance (CL): | 2.525 | Half-life (T1/2): | 0.91 |
hERG Blockers: | 0.054 | Human Hepatotoxicity (H-HT): | 0.358 |
Drug-inuced Liver Injury (DILI): | 0.007 | AMES Toxicity: | 0.045 |
Rat Oral Acute Toxicity: | 0.037 | Maximum Recommended Daily Dose: | 0.554 |
Skin Sensitization: | 0.96 | Carcinogencity: | 0.623 |
Eye Corrosion: | 0.198 | Eye Irritation: | 0.598 |
Respiratory Toxicity: | 0.811 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001094 | 0.654 | D0UE9X | 0.685 | ||||
ENC001584 | 0.597 | D0O1TC | 0.633 | ||||
ENC001535 | 0.597 | D06FEA | 0.406 | ||||
ENC001549 | 0.557 | D0O1PH | 0.404 | ||||
ENC001661 | 0.556 | D0OR6A | 0.387 | ||||
ENC001945 | 0.523 | D09SRR | 0.382 | ||||
ENC001554 | 0.500 | D0Q5XX | 0.364 | ||||
ENC001920 | 0.500 | D0G2MW | 0.364 | ||||
ENC001605 | 0.482 | D04RGA | 0.360 | ||||
ENC001660 | 0.482 | D07PCI | 0.353 |